Multidisciplinary management of acromegaly: A consensus
Carregando...
Citações na Scopus
172
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
GIUSTINA, Andrea
BARKHOUDARIAN, Garni
BECKERS, Albert
BEN-SHLOMO, Anat
BIERMASZ, Nienke
BILLER, Beverly
BOGUSZEWSKI, Cesar
BOLANOWSKI, Marek
BOLLERSLEV, Jens
BONERT, Vivien
Citação
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, v.21, n.4, p.667-678, 2020
Resumo
The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management. Focused discussions reviewed techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities are used alone or in combination. Effects of treatment on patient outcomes were considered, along with strategies for optimizing and personalizing therapeutic approaches. Expert consensus recommendations emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.
Palavras-chave
Acromegaly, Consensus, Multidisciplinary management, Medical therapy, Surgery, Radiotherapy, Pituitary tumor centers of excellence
Referências
- Agrawal N, 2020, PITUITARY, V23, P582, DOI 10.1007/s11102-020-01063-x
- Albarel F, 2018, PITUITARY, V21, P615, DOI 10.1007/s11102-018-0916-0
- Almeida JP, 2018, J NEUROSURG, V129, P404, DOI 10.3171/2017.2.JNS162673
- Alquraini H, 2018, PITUITARY, V21, P283, DOI 10.1007/s11102-018-0867-5
- Amano K, 2019, ACTA NEUROCHIR, V161, P695, DOI 10.1007/s00701-018-03778-0
- Amato G, 2002, CLIN ENDOCRINOL, V56, P65, DOI 10.1046/j.0300-0664.2001.01438.x
- Antunes X, 2018, ENDOCRINE, V60, P415, DOI 10.1007/s12020-018-1590-8
- Basavilbaso NXG, 2019, ARCH ENDOCRIN METAB, V63, P320, DOI 10.20945/2359-3997000000160
- Bernabeu I, 2013, PITUITARY, V16, P101, DOI 10.1007/s11102-012-0382-z
- Bianchi A, 2009, J CLIN ENDOCR METAB, V94, P2015, DOI 10.1210/jc.2008-1337
- Biermasz NR, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101309
- Boguszewski CL, 2019, ARCH ENDOCRIN METAB, V63, P328, DOI 10.20945/2359-3997000000159
- Bohl MA, 2016, NEUROSURGERY, V78, P84, DOI 10.1227/NEU.0000000000001003
- Brue T, 2019, ENDOCRINE, V63, P563, DOI 10.1007/s12020-018-1792-0
- Buchfelder M, 2019, BEST PRACT RES CL EN, V33, DOI 10.1016/j.beem.2019.101299
- Buchfelder M, 2018, EUR J ENDOCRINOL, V179, P419, DOI 10.1530/EJE-18-0616
- Buttan A, 2019, NEUROSURG CLIN N AM, V30, P491, DOI 10.1016/j.nec.2019.05.009
- Carmichael JD, 2009, J CLIN ENDOCR METAB, V94, P523, DOI 10.1210/jc.2008-1371
- Caron PJ, 2014, J CLIN ENDOCR METAB, V99, P1282, DOI 10.1210/jc.2013-3318
- Casanueva FF, 2017, PITUITARY, V20, P489, DOI 10.1007/s11102-017-0838-2
- Chen CJ, 2017, ACTA NEUROCHIR, V159, P2193, DOI 10.1007/s00701-017-3318-6
- Chiloiro S, 2020, J CLIN ENDOCR METAB, V105, pE100, DOI 10.1210/clinem/dgz054
- Chiloiro S, 2019, J CLIN ENDOCR METAB, V104, P5478, DOI 10.1210/jc.2019-00825
- Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z
- Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480
- Colao Annamaria, 2020, Eur J Endocrinol, V182, P583, DOI 10.1530/EJE-19-0762
- Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6
- Colao A, 2016, PITUITARY, V19, P235, DOI 10.1007/s11102-015-0684-z
- Conger A, 2019, J NEUROSURG, V130, P861, DOI 10.3171/2017.11.JNS172141
- Coopmans EC, 2020, J CLIN ENDOCR METAB, V105, P2964, DOI 10.1210/clinem/dgaa387
- Cordeiro D, 2019, J NEUROSURG, V131, P1188, DOI 10.3171/2018.5.JNS18509
- da Cunha MLV, 2020, ENDOCRINE, V68, P182, DOI 10.1007/s12020-020-02227-2
- Ding D, 2019, NEUROSURGERY, V84, P717, DOI 10.1093/neuros/nyy178
- Dogansen SC, 2018, PITUITARY, V21, P347, DOI 10.1007/s11102-018-0877-3
- de los Monteros ALE, 2009, ENDOCR PRACT, V15, P431, DOI 10.4158/EP09066.ORR
- Fahlbusch R, 2017, PITUITARY, V20, P668, DOI 10.1007/s11102-017-0832-8
- Feelders RA, 2005, J CLIN ENDOCR METAB, V90, P6480, DOI 10.1210/jc.2005-0901
- Feola T, 2019, J CLIN ENDOCR METAB, V104, P2892, DOI 10.1210/jc.2018-02281
- Fleseriu M, 2019, PITUITARY, V22, P581, DOI 10.1007/s11102-019-00986-4
- Franck SE, 2017, EUR J ENDOCRINOL, V176, P421, DOI 10.1530/EJE-16-0956
- Frara S, 2020, ENDOCRIN METAB CLIN, V49, P553, DOI 10.1016/j.ecl.2020.05.010
- Frara S, 2016, PROG MOL BIOL TRANSL, V138, P63, DOI 10.1016/bs.pmbts.2015.10.015
- Gadelha MR, 2019, ENDOCR REV, V40, P268, DOI 10.1210/er.2018-00115
- Gadelha MR, 2014, LANCET DIABETES ENDO, V2, P875, DOI 10.1016/S2213-8587(14)70169-X
- Gheorghiu ML, 2017, PITUITARY, V20, P154, DOI 10.1007/s11102-016-0783-5
- Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526
- Giustina A, 2017, J ENDOCRINOL INVEST, V40, P577, DOI 10.1007/s40618-017-0614-1
- Giustina A, 2011, PITUITARY, V14, P125, DOI 10.1007/s11102-010-0269-9
- Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670
- GIUSTINA A, 1995, AM J CARDIOL, V75, P1042, DOI 10.1016/S0002-9149(99)80721-8
- Giustina A, 2020, TRENDS ENDOCRIN MET, V31, P274, DOI 10.1016/j.tem.2020.01.011
- Giustina A, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz096
- Giustina A, 2019, PITUITARY, V22, P476, DOI 10.1007/s11102-019-00977-5
- Giustina A, 2017, J CLIN ENDOCR METAB, V102, P2454, DOI 10.1210/jc.2017-00142
- Giustina A, 2015, ENDOCRINE, V48, P3, DOI 10.1007/s12020-014-0462-0
- Giustina A, 2013, NEUROSURGERY, V73, pE746, DOI 10.1227/NEU.0000000000000068
- Giustina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036411
- Giustina A, 2009, EUR J ENDOCRINOL, V161, P331, DOI 10.1530/EJE-09-0372
- Gonzales-Virla B, 2019, ENDOCRINE, V65, P386, DOI 10.1007/s12020-019-01955-4
- Gonzalez B, 2018, J CLIN ENDOCR METAB, V103, P2369, DOI 10.1210/jc.2018-00325
- Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
- Ho KKY, 2019, PITUITARY, V22, P569, DOI 10.1007/s11102-019-00988-2
- Honegger J, 2018, PITUITARY, V21, P545, DOI 10.1007/s11102-018-0904-4
- Howlett TA, 2018, CLIN ENDOCRINOL, V88, P889
- Howlett TA, 2013, CLIN ENDOCRINOL, V79, P689, DOI 10.1111/cen.12207
- Jackson Y, 2019, PITUITARY, V22, P62, DOI 10.1007/s11102-018-00933-9
- Jane JA, 2011, J CLIN ENDOCR METAB, V96, P2732, DOI 10.1210/jc.2011-0554
- Kong DS, 2019, WORLD NEUROSURG, V122, pE1291, DOI 10.1016/j.wneu.2018.11.038
- Korkmaz OP, 2019, PITUITARY, V22, P387, DOI 10.1007/s11102-019-00968-6
- Lamberts SWJ, 2019, EUR J ENDOCRINOL, V181, pR173, DOI 10.1530/EJE-19-0074
- Espinosa-de-los-Monteros AL, 2015, PITUITARY, V18, P290, DOI 10.1007/s11102-014-0570-0
- Leonart LP, 2019, ENDOCRINE, V63, P18, DOI 10.1007/s12020-018-1729-7
- Losa M, 2016, ENDOCRINE, V52, P451, DOI 10.1007/s12020-015-0853-x
- Lv L, 2018, CLIN NEUROL NEUROSUR, V167, P24, DOI 10.1016/j.clineuro.2018.02.006
- Mazziotti G, 2010, PITUITARY, V13, P60, DOI 10.1007/s11102-009-0169-z
- Mazziotti G, 2009, J CLIN ENDOCR METAB, V94, P1500, DOI 10.1210/jc.2008-2332
- Melmed S, 2013, PITUITARY, V16, P294, DOI 10.1007/s11102-012-0420-x
- Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421
- Melmed S, 2020, NEW ENGL J MED, V382, P937, DOI 10.1056/NEJMra1810772
- Melmed S, 2018, NAT REV ENDOCRINOL, V14, P552, DOI 10.1038/s41574-018-0058-5
- Micko ASG, 2015, J NEUROSURG, V122, P803, DOI 10.3171/2014.12.JNS141083
- Minniti G, 2005, CLIN ENDOCRINOL, V62, P210, DOI 10.1111/j.1365-2265.2005.02199.x
- Mortini P, 2020, REV ENDOCR METAB DIS, V21, P527, DOI 10.1007/s11154-020-09564-7
- Mortini P, 2018, ENDOCRINE, V59, P72, DOI 10.1007/s12020-017-1458-3
- Muhammad A, 2018, J CLIN ENDOCR METAB, V103, P586, DOI 10.1210/jc.2017-02017
- Nunes VS, 2015, PITUITARY, V18, P500, DOI 10.1007/s11102-014-0602-9
- Pagliano P, 2017, INFECTION, V45, P841, DOI 10.1007/s15010-017-1056-6
- Perry A, 2019, WORLD NEUROSURG, V131, pE128, DOI 10.1016/j.wneu.2019.07.074
- Petersenn S, 2020, PITUITARY, V23, P171, DOI 10.1007/s11102-019-01020-3
- Petrossians P, 2017, ENDOCR-RELAT CANCER, V24, P505, DOI 10.1530/ERC-17-0253
- Potorac I, 2017, PITUITARY, V20, P116, DOI 10.1007/s11102-017-0788-8
- Puig-Domingo M, 2010, J CLIN ENDOCR METAB, V95, P4973, DOI 10.1210/jc.2010-0573
- Rutkowski M, 2019, NEUROSURG CLIN N AM, V30, P445, DOI 10.1016/j.nec.2019.05.005
- Sala E, 2018, J NEURO-ONCOL, V138, P291, DOI 10.1007/s11060-018-2793-9
- Samson S, 2019, J ENDOCR SOC S1, V3
- Samson Susan L, 2020, J Clin Endocrinol Metab, V105, DOI 10.1210/clinem/dgaa526
- Sandow N, 2015, PITUITARY, V18, P613, DOI 10.1007/s11102-014-0620-7
- Sandret L, 2011, J CLIN ENDOCR METAB, V96, P1327, DOI 10.1210/jc.2010-2443
- Schilbach K, 2019, EUR J ENDOCRINOL, V181, P55, DOI 10.1530/EJE-19-0139
- Schilbach K, 2017, PITUITARY, V20, P33, DOI 10.1007/s11102-017-0792-z
- Schmid HA, 2016, ENDOCRINE, V53, P210, DOI 10.1007/s12020-016-0895-8
- Strasburger CJ, 2018, EUR J ENDOCRINOL, V178, P321, DOI 10.1530/EJE-17-0996
- Suda K, 2013, ENDOCR J, V60, P507
- Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604
- van der Lely AJ, 2020, EUR J ENDOCRINOL, V182, pD17, DOI 10.1530/EJE-19-0998
- van der Lely AJ, 2017, PITUITARY, V20, P692, DOI 10.1007/s11102-017-0835-5
- van der Lely AJ, 2016, EUR J ENDOCRINOL, V175, P239, DOI 10.1530/EJE-16-0008
- van der Lely AJ, 2001, LANCET, V358, P1754, DOI 10.1016/S0140-6736(01)06844-1
- Weidlich GA, 2019, CUREUS, V11, DOI 10.7759/cureus.4275
- Whitelaw B, 2019, ENDOCR-RELAT CANCER, V26, pR545, DOI 10.1530/ERC-19-0083
- Winograd Dina, 2020, Neurosurgery, V87, P761, DOI 10.1093/neuros/nyz555